drugset / Trial / NCT01621386
Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
NaSingle-groupOpen-labelDiagnostic
Summary
This study will explore the utility of magnetic resonance imaging (MRI) to assess ventilatory defects that occur due to asthma, determine the sensitivity and specificity of MRI in response to drug treatment, and whether MRI can serve as a biomarker of treatment effects due to asthma therapy.
Timeline
- Start
- 2013-01
- Primary completion
- 2015-09
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |
| Subject | Prednisone | Other / unclassified | 20 mg | Oral |